1
SPOTIFY TECHNOLOGY S A
SHS
SPOT
SPOT
114,000
$84.8m18.30%
18.30%
Reduced Shares held: Q3 2024 149.0k, Q4 2024 145.0k, Q1 2025 145.0k, Q2 2025 114.0k
-31.0k
-31,000
-21.4%
2
TESLA INC
COM
TSLA
TSLA
242,000
$74.7m16.11%
16.11%
Added Shares held: Q3 2024 216.0k, Q4 2024 220.0k, Q1 2025 220.0k, Q2 2025 242.0k
+22.0k
+22,000
10.0%
3
SHOPIFY INC
CL A SUB VTG SHS
SHOP
SHOP
430,000
$49.0m10.57%
10.57%
Added Shares held: Q3 2024 415.0k, Q4 2024 415.0k, Q1 2025 415.0k, Q2 2025 430.0k
+15.0k
+15,000
3.6%
4
PALANTIR TECHNOLOGIES INC
CL A
PLTR
PLTR
350,000
$46.6m10.05%
10.05%
Reduced Shares held: Q3 2024 475.0k, Q4 2024 370.0k, Q1 2025 360.0k, Q2 2025 350.0k
-10.0k
-10,000
-2.8%
5
AMAZON COM INC
COM
AMZN
AMZN
149,000
$32.8m7.07%
7.07%
Added Shares held: Q3 2024 141.0k, Q4 2024 141.0k, Q1 2025 141.0k, Q2 2025 149.0k
+8.0k
+8,000
5.7%
6
SEA LTD
SPONSORD ADS
SE
SE
210,000
$32.5m7.01%
7.01%
Unchanged Shares held: Q3 2024 210.0k, Q4 2024 210.0k, Q1 2025 210.0k, Q2 2025 210.0k
7
COINBASE GLOBAL INC
COM CL A
COIN
COIN
70,000
$24.2m5.22%
5.22%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 70.0k
8
NVIDIA CORPORATION
COM
NVDA
NVDA
81,000
$12.5m2.70%
2.70%
Added Shares held: Q3 2024 73.0k, Q4 2024 73.0k, Q1 2025 73.0k, Q2 2025 81.0k
+8.0k
+8,000
11.0%
9
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
267,594
$10.7m2.31%
2.31%
Unchanged Shares held: Q3 2024 250.7k, Q4 2024 266.8k, Q1 2025 267.6k, Q2 2025 267.6k
10
PROQR THRAPEUTICS N V
SHS EURO
PRQR
PRQR
4,997,562
$10.0m2.17%
2.17%
Added Shares held: Q3 2024 5.6m, Q4 2024 5.0m, Q1 2025 5.0m, Q2 2025 5.0m
+11.9k
+11,929
0.2%
11
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
612,214
$9.9m2.13%
2.13%
Reduced Shares held: Q3 2024 333.4k, Q4 2024 380.6k, Q1 2025 629.2k, Q2 2025 612.2k
-17.0k
-17,000
-2.7%
12
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
253,304
$9.2m1.98%
1.98%
Added Shares held: Q3 2024 242.5k, Q4 2024 258.4k, Q1 2025 249.8k, Q2 2025 253.3k
+3.5k
+3,500
1.4%
13
UNIQURE NV
SHS
QURE
QURE
447,486
$6.3m1.35%
1.35%
Reduced Shares held: Q3 2024 744.9k, Q4 2024 742.2k, Q1 2025 579.1k, Q2 2025 447.5k
-131.7k
-131,653
-22.7%
14
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
52,732
$5.4m1.17%
1.17%
Unchanged Shares held: Q3 2024 80.2k, Q4 2024 62.2k, Q1 2025 52.7k, Q2 2025 52.7k
15
MERCK & CO INC
COM
MRK
MRK
59,093
$4.8m1.04%
1.04%
Added Shares held: Q3 2024 60.1k, Q4 2024 72.6k, Q1 2025 41.1k, Q2 2025 59.1k
+18.0k
+18,000
43.8%
16
ARCUTIS BIOTHERAPEUTICS INC
COM
ARQT
ARQT
344,472
$4.7m1.02%
1.02%
Added Shares held: Q3 2024 0, Q4 2024 325.7k, Q1 2025 325.7k, Q2 2025 344.5k
+18.8k
+18,763
5.8%
17
ZAI LAB LTD
ADR
ZLAB
ZLAB
132,189
$4.6m1.00%
1.00%
Unchanged Shares held: Q3 2024 215.6k, Q4 2024 185.1k, Q1 2025 132.2k, Q2 2025 132.2k
18
VERTEX PHARMACEUTICALS INC
COM
VRTX
VRTX
8,300
$3.8m0.81%
0.81%
Unchanged Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 8.3k, Q2 2025 8.3k
19
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
148,400
$3.2m0.68%
0.68%
Unchanged Shares held: Q3 2024 148.4k, Q4 2024 148.4k, Q1 2025 148.4k, Q2 2025 148.4k
20
MODERNA INC
COM
MRNA
MRNA
103,433
$3.0m0.64%
0.64%
Added Shares held: Q3 2024 40.5k, Q4 2024 82.5k, Q1 2025 75.6k, Q2 2025 103.4k
+27.9k
+27,857
36.9%
21
BIOGEN INC
COM
BIIB
BIIB
20,500
$2.7m0.58%
0.58%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 20.5k
22
CRISPR THERAPEUTICS AG
NAMEN AKT
CRSP
CRSP
44,700
$2.2m0.47%
0.47%
Reduced Shares held: Q3 2024 30.3k, Q4 2024 35.0k, Q1 2025 60.1k, Q2 2025 44.7k
-15.4k
-15,397
-25.6%
23
AMBEV SA
SPONSORED ADR
ABEV
ABEV
795,786
$1.9m0.42%
0.42%
Reduced Shares held: Q3 2024 622.3k, Q4 2024 652.4k, Q1 2025 804.2k, Q2 2025 795.8k
-8.4k
-8,420
-1.1%
24
CARVANA CO
CL A
CVNA
CVNA
5,000
$1.7m0.36%
0.36%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.0k
25
UROGEN PHARMA LTD
COM
URGN
URGN
107,622
$1.4m0.30%
0.30%
Unchanged Shares held: Q3 2024 0, Q4 2024 27.7k, Q1 2025 107.6k, Q2 2025 107.6k
26
ROIVANT SCIENCES LTD
SHS
ROIV
ROIV
126,923
$1.4m0.30%
0.30%
Unchanged Shares held: Q3 2024 484.5k, Q4 2024 215.5k, Q1 2025 126.9k, Q2 2025 126.9k
27
AVIDITY BIOSCIENCES INC
COM
RNA
RNA
46,000
$1.3m0.28%
0.28%
Added Shares held: Q3 2024 25.6k, Q4 2024 31.9k, Q1 2025 34.5k, Q2 2025 46.0k
+11.5k
+11,500
33.3%
28
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
9,320
$1.3m0.28%
0.28%
Added Shares held: Q3 2024 6.3k, Q4 2024 9.2k, Q1 2025 7.5k, Q2 2025 9.3k
+1.8k
+1,810
24.1%
29
BIONTECH SE
SPONSORED ADS
BNTX
BNTX
10,987
$1.2m0.25%
0.25%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 11.0k
30
ROCKET PHARMACEUTICALS INC
COM
RCKT
RCKT
432,760
$1.1m0.24%
0.24%
Unchanged Shares held: Q3 2024 294.8k, Q4 2024 397.6k, Q1 2025 432.8k, Q2 2025 432.8k
31
HIMS & HERS HEALTH INC
COM CL A
HIMS
HIMS
22,000
$1.1m0.24%
0.24%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 22.0k
32
MEIRAGTX HLDGS PLC
COM
MGTX
MGTX
163,000
$1.1m0.23%
0.23%
Added Shares held: Q3 2024 214.0k, Q4 2024 225.1k, Q1 2025 117.0k, Q2 2025 163.0k
+46.0k
+46,000
39.3%
33
PFIZER INC
COM
PFE
PFE
37,029
$927.2k0.20%
0.20%
Added Shares held: Q3 2024 22.0k, Q4 2024 22.0k, Q1 2025 32.3k, Q2 2025 37.0k
+4.7k
+4,702
14.6%
34
WAVE LIFE SCIENCES LTD
SHS
96663EUR
96663EUR
135,550
$883.8k0.19%
0.19%
Added Shares held: Q3 2024 48.8k, Q4 2024 88.0k, Q1 2025 113.5k, Q2 2025 135.6k
+22.0k
+22,000
19.4%
35
PAN AMERN SILVER CORP
COM
PAAS
PAAS
29,747
$844.8k0.18%
0.18%
Added Shares held: Q3 2024 26.5k, Q4 2024 21.3k, Q1 2025 21.3k, Q2 2025 29.7k
+8.5k
+8,463
39.8%
36
NOV INC
COM
NOV
NOV
63,876
$825.3k0.18%
0.18%
Added Shares held: Q3 2024 37.9k, Q4 2024 42.9k, Q1 2025 49.7k, Q2 2025 63.9k
+14.1k
+14,131
28.4%
37
4D MOLECULAR THERAPEUTICS IN
COM
FDMT
FDMT
197,458
$819.5k0.18%
0.18%
Added Shares held: Q3 2024 98.5k, Q4 2024 121.0k, Q1 2025 131.0k, Q2 2025 197.5k
+66.5k
+66,458
50.7%
38
SPROTT FDS TR
URANIUM MINERS E
URNM
URNM
16,278
$761.2k0.16%
0.16%
Added Shares held: Q3 2024 8.9k, Q4 2024 10.3k, Q1 2025 12.1k, Q2 2025 16.3k
+4.2k
+4,164
34.4%
39
LEXEO THERAPEUTICS INC
COM
LXEO
LXEO
178,356
$752.7k0.16%
0.16%
Added Shares held: Q3 2024 0, Q4 2024 138.1k, Q1 2025 160.2k, Q2 2025 178.4k
+18.2k
+18,158
11.3%
40
VIZSLA SILVER CORP
COM NEW
VZLA
VZLA
250,790
$732.3k0.16%
0.16%
Added Shares held: Q3 2024 116.5k, Q4 2024 116.5k, Q1 2025 192.5k, Q2 2025 250.8k
+58.3k
+58,303
30.3%
41
SAREPTA THERAPEUTICS INC
COM
SRPT
SRPT
39,400
$697.8k0.15%
0.15%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 39.4k
42
AUTOLUS THERAPEUTICS PLC
SPON ADS
AUTL
AUTL
294,142
$673.6k0.15%
0.15%
Added Shares held: Q3 2024 185.6k, Q4 2024 231.7k, Q1 2025 251.7k, Q2 2025 294.1k
+42.5k
+42,468
16.9%
43
SEABRIDGE GOLD INC
COM
COM
44,074
$648.3k0.14%
0.14%
Unchanged Shares held: Q3 2024 32.1k, Q4 2024 36.0k, Q1 2025 44.1k, Q2 2025 44.1k
44
RECURSION PHARMACEUTICALS IN
CL A
RXRX
RXRX
119,000
$610.5k0.13%
0.13%
Unchanged Shares held: Q3 2024 78.0k, Q4 2024 119.0k, Q1 2025 119.0k, Q2 2025 119.0k
45
VALARIS LTD
CL A
VAL
VAL
13,803
$606.0k0.13%
0.13%
Reduced Shares held: Q3 2024 7.6k, Q4 2024 14.2k, Q1 2025 20.2k, Q2 2025 13.8k
-6.4k
-6,419
-31.7%
46
EMX RTY CORP
COM
EMX
EMX
216,968
$544.6k0.12%
0.12%
Unchanged Shares held: Q3 2024 0, Q4 2024 217.0k, Q1 2025 217.0k, Q2 2025 217.0k
47
SANDRIDGE ENERGY INC
COM NEW
SD
SD
37,022
$400.9k0.09%
0.09%
Added Shares held: Q3 2024 23.3k, Q4 2024 23.3k, Q1 2025 23.3k, Q2 2025 37.0k
+13.7k
+13,722
58.9%
48
NOBLE CORP PLC
ORD SHS A
NE
NE
14,287
$392.0k0.08%
0.08%
Unchanged Shares held: Q3 2024 10.5k, Q4 2024 10.5k, Q1 2025 14.3k, Q2 2025 14.3k
49
TAYSHA GENE THERAPIES INC
COM SHS
TSHA
TSHA
134,900
$315.7k0.07%
0.07%
Unchanged Shares held: Q3 2024 120.0k, Q4 2024 134.9k, Q1 2025 134.9k, Q2 2025 134.9k
50
TIDEWATER INC NEW
COM
TDW
TDW
5,350
$255.2k0.06%
0.06%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.3k
51
SIBANYE STILLWATER LTD
SPONSORED ADR
SBSW
SBSW
34,040
$247.8k0.05%
0.05%
Unchanged Shares held: Q3 2024 34.0k, Q4 2024 34.0k, Q1 2025 34.0k, Q2 2025 34.0k
52
DYNE THERAPEUTICS INC
COM
DYN
DYN
27,566
$239.3k0.05%
0.05%
Unchanged Shares held: Q3 2024 15.0k, Q4 2024 20.4k, Q1 2025 27.6k, Q2 2025 27.6k
53
ALX ONCOLOGY HLDGS INC
COM
ALXO
ALXO
509,059
$220.6k0.05%
0.05%
Unchanged Shares held: Q3 2024 509.1k, Q4 2024 509.1k, Q1 2025 509.1k, Q2 2025 509.1k
54
FATE THERAPEUTICS INC
COM
FATE
FATE
111,090
$126.6k0.03%
0.03%
Added Shares held: Q3 2024 50.0k, Q4 2024 87.0k, Q1 2025 109.0k, Q2 2025 111.1k
+2.1k
+2,064
1.9%
55
VOYAGER THERAPEUTICS INC
COM
VYGR
VYGR
25,241
$78.8k0.02%
0.02%
Added Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 21.6k, Q2 2025 25.2k
+3.6k
+3,596
16.6%